Clinical Research Directory
Browse clinical research sites, groups, and studies.
Disease Outcomes and Toxicities in Patients With Gastrointestinal and Sarcomatous Malignancies
Sponsor: UNC Lineberger Comprehensive Cancer Center
Summary
This prospective, single-institution, observational study explores disease outcomes and toxicities in subjects with gastrointestinal malignancies and sarcoma (bone and soft tissue) who are being treated with standard-of-care therapies including radiotherapy. Recent advances in treatment approaches affected disease outcomes and toxicities. Prospective monitoring of disease outcomes and toxicities using standardized assessments will provide information about recent changes in the standard of care and further refine treatment approaches and prospective clinical trial design.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
180
Start Date
2023-03-17
Completion Date
2036-01-01
Last Updated
2026-03-30
Healthy Volunteers
No
Conditions
Interventions
Survey
Patient Reported Outcome (PRO) questionnaire
Toxicity Assessments
Toxicity Assessments will be performed using the National Cancer Institute Common Terminology Criteria (NCI-CTCAE).
Locations (1)
University of North Carolina at Chapel Hill, Department of Radiation Oncology
Chapel Hill, North Carolina, United States